| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |